<table class="naaccr-summary-table naaccr-borders">
    <tr>
        <th class="naaccr-summary-header naaccr-borders">Item #</th>
        <th class="naaccr-summary-header naaccr-borders">Length</th>
        <th class="naaccr-summary-header naaccr-borders">Source of Standard</th>
        <th class="naaccr-summary-header naaccr-borders">Year Implemented</th>
        <th class="naaccr-summary-header naaccr-borders">Version Implemented</th>
        <th class="naaccr-summary-header naaccr-borders">Year Retired</th>
        <th class="naaccr-summary-header naaccr-borders">Version Retired</th>
        <th class="naaccr-summary-header naaccr-borders">Column #</th>
    </tr>
    <tr>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">1570</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">CoC</td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered"></td>
        <td class="naaccr-summary-cell naaccr-borders naaccr-summary-centered">2264 - 2265</td>
    </tr>
</table>

<br/><strong>NAACCR XML</strong>: Tumor.radRegionalRxModality<br/><br/>
<strong>Alternate Names</strong>
<br/>&nbsp;&nbsp;&nbsp;Regional Treatment Modality (CoC)


<div class='content chap10-para-head'><strong><strong>Description</strong></strong></div>
<div class='content chap10-para'>Records the dominant modality of radiation therapy used to deliver the clinically most significant regional dose to the primary volume of interest during the first course of treatment.</div>
<div class='content chap10-para-head'><strong><strong>Rationale</strong></strong></div>
<div class='content chap10-para'>Radiation treatment frequently is delivered in two or more phases that can be summarized as regional and boost treatments. To evaluate patterns of radiation oncology care, it is necessary to know which radiation resources were employed in the delivery of therapy. For outcomes analysis, the modalities used for each of these phases can be very important.</div>
<div class='content chap10-para'><strong>Codes</strong></div>
<div class='content chap10-para'>
    <table>
        <tr class='code-row'>
            <td class='code-nbr'>00</td>
            <td class='code-desc'>No radiation treatment</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>20</td>
            <td class='code-desc'>External beam, NOS</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>21</td>
            <td class='code-desc'>Orthovoltage</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>22</td>
            <td class='code-desc'>Cobalt-60, Cesium-137</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>23</td>
            <td class='code-desc'>Photons (2-5 MV)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>24</td>
            <td class='code-desc'>Photons (6-10 MV)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>25</td>
            <td class='code-desc'>Photons (11-19 MV)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>26</td>
            <td class='code-desc'>Photons (> 19 MV)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>27</td>
            <td class='code-desc'>Photons (mixed energies)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>28</td>
            <td class='code-desc'>Electrons</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>29</td>
            <td class='code-desc'>Photons and electrons mixed</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>30</td>
            <td class='code-desc'>Neutrons, with or without photons/electrons</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>31</td>
            <td class='code-desc'>IMRT</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>32</td>
            <td class='code-desc'>Conformal or 3-D therapy</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>40</td>
            <td class='code-desc'>Protons</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>41</td>
            <td class='code-desc'>Stereotactic radiosurgery, NOS</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>42</td>
            <td class='code-desc'>Linac radiosurgery</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>43</td>
            <td class='code-desc'>Gamma Knife</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>50</td>
            <td class='code-desc'>Brachytherapy, NOS</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>51</td>
            <td class='code-desc'>Brachytherapy, Intracavitary, Low Dose Rate (LDR)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>52</td>
            <td class='code-desc'>Brachytherapy, Intracavitary, High Dose Rate (HDR)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>53</td>
            <td class='code-desc'>Brachytherapy, Interstitial, Low Dose Rate (LDR)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>54</td>
            <td class='code-desc'>Brachytherapy, Interstitial, High Dose Rate (HDR)</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>55</td>
            <td class='code-desc'>Radium</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>60</td>
            <td class='code-desc'>Radio-isotopes, NOS</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>61</td>
            <td class='code-desc'>Strontium - 89</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>62</td>
            <td class='code-desc'>Strontium - 90</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>80*</td>
            <td class='code-desc'>Combination modality, specified</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>85*</td>
            <td class='code-desc'>Combination modality, NOS</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>98</td>
            <td class='code-desc'>Other, NOS</td>
        </tr>
        <tr class='code-row'>
            <td class='code-nbr'>99</td>
            <td class='code-desc'>Unknown</td>
        </tr>
    </table>
</div>
<div class='content chap10-para'><p>
    <em>Note: </em>For tumors diagnosed prior to January 1, 2003, the codes reported in this data item describe any radiation administered to the patient as part or all of the first course of therapy.
    <br/><br/> *Codes 80 and 85 describe specific converted descriptions of radiation therapy coded according to
    <em>Volume II ROADS</em>, and<em> DAM </em>rules and should only be used to record regional radiation for tumors diagnosed prior to January 1, 2003. </p></div>